Rheumatoid arthritis is linked to oral bacteria: Etiological association

Modern Rheumatology

Volumn 19, Issue 5, 2009, Pages 453-456

  Ogrendik, Mesut ^a,b  

^a Nazilli State Hospital   (Turkey)

^b Altintas mah Kocacami cad   (Turkey)

Author keywords

Etiopathogenesis; Oral bacteria; Rheumatoid arthritis

Indexed keywords

ALPHA ENOLASE; ALPHA ENOLASE PEPTIDE 1; ARGININE; BACTERIUM ANTIBODY; CLARITHROMYCIN; COLLAGEN ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FIBRIN; GALACTOSE; HEAT SHOCK PROTEIN; HLA DR4 ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 17; LEVOFLOXACIN; MINOCYCLINE; ORNIDAZOLE; PLACEBO; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ANAEROBIC BACTERIUM; ANTIBODY DETECTION; BACTERIUM IDENTIFICATION; CELL ACTIVITY; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; ENTERITIS; HUMAN; IMMUNOMODULATION; MOUTH FLORA; MOUTH INFECTION; NONHUMAN; PATHOGENESIS; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; TANNERELLA FORSYTHENSIS; TH17 CELL;

ARTHRITIS, RHEUMATOID; BACTEROIDACEAE INFECTIONS; GRAM-NEGATIVE ANAEROBIC BACTERIA; HUMANS; MOUTH; PERIODONTAL DISEASES; SALIVA;

EID: 70350097884     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0194-9     Document Type: Review

References (53)

1. Tatakis DN, Kumar PS. Etiology and pathogenesis of periodontal diseases. Dent Clin North Am. 2005;49:491-516.
2. Greenwald RA, Kirkwood K. Adult periodontitis as a model for rheumatoid arthritis (with emphasis on treatment strategies). J Rheumatol. 1999;26:1650-3.
3. Mercado FB, Marshall RI, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and periodontitis. J Periodontol. 2001;72:779-87.
4. Rosenstein ED, Greenwald RA, Kushner LJ, Weissmann G. Hypothesis: The humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation. 2004;28:311-8.
5. Moen K, Brun JG, Madland TM, Tynning T, Jonsson R. Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients. Clin Diagn Lab Immunol. 2003;10:1043-50.
6. Ogrendik M, Kokino S, Ozdemir F, Bird PS, Hamlet S. Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis. MedGenMed. 2005 Jun 16;7(2):2. http://www.medscape.com/viewarticle/ 505458. Accessed 16 June 2005.
7. Moen K, Brun JG, Valen M, et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol. 2006;24:656-63.
8. Ogrendik M, Hakguder A, Keser N. Treatment of rheumatoid arthritis with ornidazole. A randomized, double-blind, placebo-controlled study. Rheumatology (Oxford). 2006;45:636-7.
9. Ogrendik M. Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate. South Med J. 2007;100:135-9.
10. Ogrendik M. Effects of clarithromycin in patients with active rheumatoid arthritis. Curr Med Res Opin. 2007;23:515-22.
11. Das KM. Sulfasalazine therapy in inflammatory bowel disease. Gastroenterol Clin North Am. 1989;18:1-20.
12. Amin AR, Attur MG, Thakker GD, et al. A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases. Proc Natl Acad Sci USA. 1996;93:14014-9.
13. Tilley BC, Alarcon GS, Heyse SP, et al. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med. 1995;122:81-9.
14. Kloppenburg M, Breedveld FC, Terwiel JP, Mallee C, Dijkmans BA. Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum. 1994;37:629-36.
15. O'Dell JR, Haire CE, Palmer W, et al. Treatment of early rheumatoid arthritis with minocycline or placebo: Results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 1997;40:842-8.
16. O'Dell JR, Paulsen G, Haire CE, et al. Treatment of early seropositive rheumatoid arthritis with minocycline: Four-year followup of a double-blind, placebo-controlled trial. Arthritis Rheum. 1999;42:1691-5.
17. Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med. 1997;337:141-7.
18. Seymour GJ, Gemmell E. Cytokines in periodontal disease: Where to from here? Acta Odontol Scand. 2001;59:167-73.
19. Yoshimura A, Hara Y, Kaneko T, Kato I. Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria. J Periodontal Res. 1997;32:279-86.
20. Kjeldsen M, Holmstrup P, Lindemann RA, Bendtzen K. Bacterial-stimulated cytokine production of peripheral mononuclear cells from patients of various periodontitis categories. J Periodontol. 1995;66:139-44.
21. Rossano F, Rizzo A, Sanges MR, Cipollaro de L'Ero G, Tufano MA. Human monocytes and gingival fibroblasts release tumor necrosis factor-alpha, interleukin-1 alpha and interleukin-6 in response to particulate and soluble fractions of Prevotella melaninogenica and Fusobacterium nucleatum. Int J Clin Lab Res. 1993;23:165-8.
22. Robinson AJ, Taylor DH, Wright GD. Infliximab therapy reduces periodontoid rheumatoid pannus formation. Rheumatology (Oxford). 2008;47:225-6.
23. McGraw WT, Potempa J, Farley D, Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun. 1999;67:3248-56.
24. Gargiulo AV Jr, Robinson J, Toto PD, Gargiulo AW. Identification of rheumatoid factor in periodontal disease. J Periodontol. 1982;53:568-77.
25. Thé J, Ebersole JL. Rheumatoid factor (RF) distribution in periodontal disease. J Clin Immunol. 1991;11:132-42.
26. Tighe H, Carson DA. Rheumatoid factor. In: Ruddy S, Harris Jr. ED, Sledge CB, editors. Kelley's textbook of rheumatology. Philadelphia: WB Saunders; 2001. p. 151-60.
27. Bonagura VR, Artandi SE, Davidson A, et al. Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors. J Immunol. 1993;151:3840-52.
28. Martin T, Crouzier R, Weber JC, Kipps TJ, Pasquali JL. Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain. J Immunol. 1994;152:5988-96.
29. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med. 1978;298:869-71.
30. Katz J, Goultschin J, Benoliel R, Brautbar C. Human leukocyte antigen (HLA) DR4. Positive association with rapidly progressing periodontitis. J Periodontol. 1987;58:607-10.
31. Gran JT, Husby G, Thorsby E. The association between rheumatoid arthritis and HLA antigen DR4. Ann Rheum Dis. 1983;42:292-6.
32. Bonfil JJ, Dillier FL, Mercier P, et al. A "case control" study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodontitis. Identification of types and subtypes using molecular biology (PCR.SSO). J Clin Periodontol. 1999;26:77-84.
33. Lacki JK, Porawska W, Mackiewicz U, Mackiewicz S, Muller W. Changes in agalactosyl IgG levels correlate with radiological progression in early rheumatoid arthritis. Ann Med. 1996;28:265-9.
34. Haraldsson G, Meurman JH, Kononen E, Holbrook WP. Properties of hemagglutination by Prevotella melaninogenica. Anaerobe. 2005;11:285-9.
35. Cuesta IA, Sud S, Song Z, Affholter JA, et al. T-cell receptor (V beta) bias in the response of rheumatoid arthritis synovial fluid T cells to connective tissue antigens. Scand J Rheumatol. 1997;26:166-73.
36. Hall FC, Thomson K, Procter J, McMichael AJ, Wordsworth BP. TCR beta spectratyping in RA: Evidence of clonal expansions in peripheral blood lymphocytes. Ann Rheum Dis. 1998;57:319-22.
37. Leung KP, Torres BA. Prevotella intermedia stimulates expansion of Vbeta-specific CD4(+) T cells. Infect Immun. 2000;68:5420-4.
38. Mathur A, Michalowicz B, Yang C, Aeppli D. Influence of periodontal bacteria and disease status on V beta expression in T cells. J Periodontal Res. 1995;30:369-73.
39. Yoshida A, Nakano Y, Yamashita Y, et al. Immunodominant region of Actinobacillus actinomycetemcomitans 40-kilodalton heat shock protein in patients with rheumatoid arthritis. J Dent Res. 2001;80:346-50.
40. Ando T, Kato T, Ishihara K, Ogiuchi H, Okuda K. Heat shock proteins in the human periodontal disease process. Microbiol Immunol. 1995;39:321-7.
41. Schett G, Redlich K, Xu Q, et al. Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs. J Clin Invest. 1998;102:302-11.
42. Clague RB, Firth SA, Holt PJ, Skingle J, Greenbury CL, Webley M. Serum antibodies to type II collagen in rheumatoid arthritis: Comparison of 6 immunological methods and clinical features. Ann Rheum Dis. 1983;42:537-44.
43. Ronnelid J, Lysholm J, Engstrom-Laurent A, Klareskog L, Heyman B. Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum. 1994;37:1023-9.
44. Bedi GS, Williams T. Purification and characterization of a collagen-degrading protease from Porphyromonas gingivalis. J Biol Chem. 1994;269:599-606.
45. Backlund J, Carlsen S, Hoger T, et al. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci USA. 2002;99:9960-5.
46. Van den Steen PE, Proost P, Grillet B, et al. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J. 2002;16:379-89.
47. Imamura T. The role of gingipains in the pathogenesis of periodontal disease. J Periodontol. 2003;74:111-8.
48. Andersen RB, Elling P. Immunofluorescent demonstration of intracellular fibrin in synovial tissue. Ann Rheum Dis. 1972;31:59-64.
49. Lundberg K, Kinloch A, Fisher BA, et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 2008;58:3009-19.
50. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223:87-113.
51. Cardoso CR, Garlet GP, Crippa GE, et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol. 2009;24:1-6.
52. Kramer JM, Gaffen SL. Interleukin-17: A new paradigm in inflammation, autoimmunity, and therapy. J Periodontol. 2007;78:1083-93.
53. Oda T, Yoshie H, Yamazaki K. Porphyromonas gingivalis antigen preferentially stimulates T cells to express IL-17 but not receptor activator of NF-kappaB ligand in vitro. Oral Microbiol Immunol. 2003;18:30-6.